Barotrauma in Coronavirus Disease 2019 Patients Undergoing Invasive Mechanical Ventilation: A Systematic Literature Review

Alessandro Belletti, Gabriele Todaro, Gabriele Valsecchi, Rosario Losiggio, Diego Palumbo, Giovanni Landoni, Alberto Zangrillo, Alessandro Belletti, Gabriele Todaro, Gabriele Valsecchi, Rosario Losiggio, Diego Palumbo, Giovanni Landoni, Alberto Zangrillo

Abstract

Objective: There are concerns of a high barotrauma rate in coronavirus disease 2019 patients with acute respiratory distress syndrome receiving invasive mechanical ventilation. However, a few studies were published, and reported rates were highly variable. We performed a systematic literature review to identify rates of barotrauma, pneumothorax, and pneumomediastinum in coronavirus disease 2019 acute respiratory distress syndrome patients receiving invasive mechanical ventilation.

Data source: PubMed and Scopus were searched for studies reporting barotrauma event rate in adult coronavirus disease 2019 patients receiving invasive mechanical ventilation.

Study selection: We included all studies investigating adult patients with coronavirus disease 2019 acute respiratory distress syndrome requiring mechanical ventilation. Case reports, studies performed outside ICU setting, and pediatric studies were excluded. Two investigators independently screened and selected studies for inclusion.

Data extraction: Two investigators abstracted data on study characteristics, rate of pneumothorax, pneumomediastinum and overall barotrauma events, and mortality. When available, data from noncoronavirus disease 2019 acute respiratory distress syndrome patients were also collected. Pooled estimates for barotrauma, pneumothorax, and pneumomediastinum were calculated.

Data synthesis: A total of 13 studies with 1,814 invasively ventilated coronavirus disease 2019 patients and 493 noncoronavirus disease 2019 patients were included. A total of 266/1,814 patients (14.7%) had at least one barotrauma event (pooled estimates, 16.1% [95% CI, 11.8-20.4%]). Pneumothorax occurred in 132/1,435 patients (pooled estimates, 10.7%; 95% CI, 6.7-14.7%), whereas pneumomediastinum occurred in 162/1,432 patients (pooled estimates, 11.2%; 95% CI, 8.0-14.3%). Mortality in coronavirus disease 2019 patients who developed barotrauma was 111/198 patients (pooled estimates, 61.6%; 95% CI, 50.2-73.0%). In noncoronavirus disease 2019 acute respiratory distress syndrome patients, barotrauma occurred in 31/493 patients (6.3%; pooled estimates, 5.7%; 95% CI, -2.1% to 13.5%).

Conclusions: Barotrauma occurs in one out of six coronavirus disease 2019 acute respiratory distress syndrome patients receiving invasive mechanical ventilation and is associated with a mortality rate of about 60%. Barotrauma rate may be higher than noncoronavirus disease 2019 controls.

Conflict of interest statement

The authors have disclosed that they do not have any potential conflicts of interest.

Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Figures

Figure 1.
Figure 1.
Flow diagram for included studies.
Figure 2.
Figure 2.
Forest plot for barotrauma rate in COVID-19 ARDS patients. Individual and pooled estimates (%) are reported on the y-axis. Black diamonds indicate individual estimates, and black lines indicate individual 95% CIs. Gray squares represent individual study weights. The vertical red dashed line indicates pooled estimate. The vertical axis of the white diamond indicates pooled estimate, whereas the horizontal axis indicates pooled 95% CI. ES: estimate.

References

    1. Zhu N, Zhang D, Wang W, et al. ; China Novel Coronavirus Investigating and Research Team: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:727–733
    1. WHO Coronavirus Disease (COVID-19) Dashboard: WHO Coronavirus Disease (COVID-19) Dashboard. Available at: . Accessed June 15, 2021
    1. Zangrillo A, Beretta L, Scandroglio AM, et al. ; COVID-BioB Study Group: Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020; 22:200–211
    1. Grasselli G, Zangrillo A, Zanella A, et al. ; COVID-19 Lombardy ICU Network: Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020; 323:1574–1581
    1. Grasselli G, Greco M, Zanella A, et al. ; COVID-19 Lombardy ICU Network: Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020; 180:1345–1355
    1. Monti G, Cremona G, Zangrillo A, et al. : Home ventilators for invasive ventilation of patients with COVID-19. Crit Care Resusc. 2020; 22:266–270
    1. Zangrillo A, Beretta L, Silvani P, et al. : Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: Facing the COVID-19 pandemic emergency. Crit Care Resusc. 2020; 22:91–94
    1. Rosenbaum L: Facing Covid-19 in Italy - ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med. 2020; 382:1873–1875
    1. Guérin C, Reignier J, Richard JC, et al. ; PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013; 368:2159–2168
    1. Villar J, Ferrando C, Martínez D, et al. ; dexamethasone in ARDS network: Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir Med. 2020; 8:267–276
    1. Moss M, Huang DT, Brower RG, et al. : Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019; 380:1997–2008
    1. Cavalcanti AB, Suzumura ÉA, Laranjeira LN, et al. : Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome - a randomized clinical trial. JAMA. 2017; 318:1335–1345
    1. Anzueto A, Frutos-Vivar F, Esteban A, et al. : Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Med. 2004; 30:612–619
    1. Zhou C, Gao C, Xie Y, et al. : COVID-19 with spontaneous pneumomediastinum. Lancet Infect Dis. 2020; 20:510.
    1. Loffi M, Regazzoni V, Sergio P, et al. : Spontaneous pneumomediastinum in COVID-19 pneumonia. Monaldi Arch Chest Dis. 2020; 90:604–607
    1. Lei P, Mao J, Wang P: Spontaneous pneumomediastinum in a patient with coronavirus disease 2019 pneumonia and the possible underlying mechanism. Korean J Radiol. 2020; 21:929–930
    1. Wali A, Rizzo V, Bille A, et al. : Pneumomediastinum following intubation in COVID-19 patients: A case series. Anaesthesia. 2020; 75:1076–1081
    1. Lemmers DHL, Abu Hilal M, Bnà C, et al. : Pneumomediastinum and subcutaneous emphysema in COVID-19: Barotrauma or lung frailty? ERJ Open Res. 2020; 6:00385–02020
    1. Belletti A, Palumbo D, Zangrillo A, et al. . Predictors of pneumothorax/pneumomediastinum in mechanically ventilated COVID-19 patients. J Cardiothorac Vasc Anesth. 2021. Feb 6. [online ahead of print]
    1. McGuinness G, Zhan C, Rosenberg N, et al. : Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology. 2020; 297:E252–E262
    1. Palumbo D, Campochiaro C, Belletti A, et al. ; COVID-BioB Study Group: Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: Differences between first and second Italian pandemic wave. Eur J Intern Med. 2021; 88:144–146
    1. Liberati A, Altman DG, Tetzlaff J, et al. : The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med. 2009; 151:W65–W94
    1. Moher D, Liberati A, Tetzlaff J, et al. ; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol. 2009; 62:1006–1012
    1. Greco T, Zangrillo A, Biondi-Zoccai G, et al. : Meta-analysis: Pitfalls and hints. Heart Lung Vessel. 2013; 5:219–225
    1. Biondi-Zoccai G, Lotrionte M, Landoni G, et al. : The rough guide to systematic reviews and meta-analyses. HSR Proc Intensive Care Cardiovasc Anesth. 2011; 3:161–173
    1. Higgins J, Thomas J, Chandler J, et al. (Eds): Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester, UK, John Wiley & Sons, 2019
    1. Sterne JA, Hernán MA, Reeves BC, et al. : ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919.
    1. ROBINS-E. Bristol Medical School: Population Health Sciences. University of Bristol. 2017. Available at: . Accessed January 7, 2021
    1. Capaccione KM, D’souza B, Leb J, et al. : Pneumothorax rate in intubated patients with COVID-19. Acute Crit Care. 2021; 36:81–84
    1. Wang XH, Duan J, Han X, et al. : High incidence and mortality of pneumothorax in critically ill patients with COVID-19. Heart Lung. 2021; 50:37–43
    1. Yao W, Wang T, Jiang B, et al. ; Collaborators: Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: Lessons learnt and international expert recommendations. Br J Anaesth. 2020; 125:e28–e37
    1. Housman B, Jacobi A, Carollo A, et al. : COVID-19 ventilator barotrauma management: Less is more. Ann Transl Med. 2020; 8:1575.
    1. Mart MF, Norfolk SG, Flemmons LN, et al. : Pneumomediastinum in acute respiratory distress syndrome from COVID-19. Am J Respir Crit Care Med. 2021; 203:237–238
    1. Kahn MR, Watson RL, Thetford JT, Wong JI, Kamangar N: High incidence of barotrauma in patients with severe coronavirus disease 2019. J Intensive Care Med. 2021; 36:646–654
    1. Fiacchini G, Tricò D, Ribechini A, et al. : Evaluation of the incidence and potential mechanisms of tracheal complications in patients with COVID-19. JAMA Otolaryngol Head Neck Surg. 2021; 147:70–76
    1. Udi J, Lang CN, Zotzmann V, et al. : Incidence of barotrauma in patients with COVID-19 pneumonia during prolonged invasive mechanical ventilation - a case-control study. J Intensive Care Med. 2021; 36:477–483
    1. Edwards JA, Breitman I, Bienstock J, et al. : Pulmonary barotrauma in mechanically ventilated coronavirus disease 2019 patients: A case series. Ann Med Surg (Lond). 2021; 61:24–29
    1. Talan L, Şaşal Solmaz FG, Ercan U, et al. : COVID-19 pneumonia and pneumothorax: Case series. Tuberk Toraks. 2020; 68:437–443
    1. Macklin CC: Transport of air along sheaths of pulmonic blood vessels from alveoli to mediastinum: Clinical implications. Arch Intern Med. 1939; 64:913–926
    1. Murayama S, Gibo S: Spontaneous pneumomediastinum and Macklin effect: Overview and appearance on computed tomography. World J Radiol. 2014; 6:850–854
    1. Fagiuoli S, Lorini FL, Remuzzi G; Covid-19 Bergamo Hospital Crisis Unit: Adaptations and lessons in the province of Bergamo. N Engl J Med. 2020; 382:e71.
    1. Grasselli G, Pesenti A, Cecconi M: Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response. JAMA. 2020; 323:1545–1546
    1. Protti A, Greco M, Filippini M, et al. : Barotrauma in mechanically ventilated patients with coronavirus disease 2019: A survey of 38 hospitals in Lombardy, Italy. Minerva Anestesiol. 2021; 87:193–198
    1. Papazian L, Forel JM, Gacouin A, et al. ; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363:1107–1116
    1. Bellani G, Laffey JG, Pham T, et al. ; LUNG SAFE Investigators; ESICM Trials Group: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016; 315:788–800
    1. Fan E, Del Sorbo L, Goligher EC, et al. ; American Thoracic Society, European Society of Intensive Care Medicine, and Society of Critical Care Medicine: An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017; 195:1253–1263
    1. Ciceri F, Beretta L, Scandroglio AM, et al. : Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): An atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020; 22:95–97
    1. Fahmy OH, Daas FM, Salunkhe V, et al. : Is microthrombosis the main pathology in coronavirus disease 2019 severity?-A systematic review of the postmortem pathologic findings. Crit Care Explor. 2021; 3:e0427.
    1. Konopka KE, Nguyen T, Jentzen JM, et al. : Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 infection is morphologically indistinguishable from other causes of DAD. Histopathology. 2020; 77:570–578
    1. Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. ; COVID-19 Spanish ICU Network: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020; 46:2200–2211

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅